FI941749A - Rekombinantti-Borrelia -proteiinien valmistus - Google Patents
Rekombinantti-Borrelia -proteiinien valmistus Download PDFInfo
- Publication number
- FI941749A FI941749A FI941749A FI941749A FI941749A FI 941749 A FI941749 A FI 941749A FI 941749 A FI941749 A FI 941749A FI 941749 A FI941749 A FI 941749A FI 941749 A FI941749 A FI 941749A
- Authority
- FI
- Finland
- Prior art keywords
- borreali
- recombinant
- proteins
- preparation
- recombinant borreali
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77904891A | 1991-10-18 | 1991-10-18 | |
US88876592A | 1992-05-27 | 1992-05-27 | |
PCT/US1992/008697 WO1993008299A1 (en) | 1991-10-18 | 1992-10-16 | Preparation of recombinant borrelia proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
FI941749A0 FI941749A0 (fi) | 1994-04-15 |
FI941749A true FI941749A (fi) | 1994-05-25 |
Family
ID=27119531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI941749A FI941749A (fi) | 1991-10-18 | 1994-04-15 | Rekombinantti-Borrelia -proteiinien valmistus |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0620860A4 (xx) |
JP (1) | JPH06511154A (xx) |
AU (1) | AU676140B2 (xx) |
CA (1) | CA2121121C (xx) |
FI (1) | FI941749A (xx) |
IL (1) | IL103462A0 (xx) |
NO (1) | NO310417B1 (xx) |
PT (1) | PT100980B (xx) |
WO (1) | WO1993008299A1 (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4015911A1 (de) * | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
US6676942B1 (en) | 1991-08-15 | 2004-01-13 | Smithkline Beecham Biologicals (S.A.) | Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
DE69229476T2 (de) * | 1991-08-15 | 2000-03-16 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe |
CA2105629A1 (en) * | 1992-09-14 | 1994-03-15 | Robert S. Becker | Potentiation of immunogenic response |
US6248562B1 (en) | 1993-11-01 | 2001-06-19 | Research Foundation State University Of New York | Chimeric proteins comprising borrelia polypeptides and uses therefor |
US7008625B2 (en) | 1993-11-01 | 2006-03-07 | Research Foundation Of The State University Of New York | Recombinant constructs of Borrelia burgdorferi |
US6610838B1 (en) | 1997-09-10 | 2003-08-26 | Symbicom Aktiebolag | P13 antigens from Borrelia |
US6224882B1 (en) | 1997-11-07 | 2001-05-01 | Protein Science Corp. | Insect cells or fractions as adjuvant for antigens |
GB9811219D0 (en) * | 1998-05-26 | 1998-07-22 | Smithkline Beecham Biolog | Novel process |
WO2000063386A2 (en) * | 1999-04-21 | 2000-10-26 | Boston Medical Center Corporation | Prevention, diagnosis and treatment of lyme disease |
EP1311540B1 (en) | 2000-08-18 | 2007-12-19 | Research Foundation Of State University Of New York | Altered ospa of borrelia burgdorferi |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK590288D0 (da) * | 1988-10-24 | 1988-10-24 | Symbicom Ab | Kemiske forbindelser |
DE4015911A1 (de) * | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
AU7058691A (en) * | 1989-12-22 | 1991-07-24 | Mikrogen Molekularbiologische Entwicklungs-Gmbh | Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
CA2057536C (en) * | 1990-12-21 | 1999-10-26 | John J. Dunn | Cloning and expression of borrelia lipoproteins |
DE69229476T2 (de) * | 1991-08-15 | 2000-03-16 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe |
-
1992
- 1992-10-16 PT PT100980A patent/PT100980B/pt not_active IP Right Cessation
- 1992-10-16 EP EP92922390A patent/EP0620860A4/en not_active Withdrawn
- 1992-10-16 AU AU28011/92A patent/AU676140B2/en not_active Ceased
- 1992-10-16 JP JP5507751A patent/JPH06511154A/ja active Pending
- 1992-10-16 WO PCT/US1992/008697 patent/WO1993008299A1/en not_active Application Discontinuation
- 1992-10-16 CA CA002121121A patent/CA2121121C/en not_active Expired - Fee Related
- 1992-10-18 IL IL103462A patent/IL103462A0/xx unknown
-
1994
- 1994-04-15 FI FI941749A patent/FI941749A/fi unknown
- 1994-04-15 NO NO19941376A patent/NO310417B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU676140B2 (en) | 1997-03-06 |
IL103462A0 (en) | 1993-03-15 |
NO941376D0 (no) | 1994-04-15 |
EP0620860A1 (en) | 1994-10-26 |
AU2801192A (en) | 1993-05-21 |
FI941749A0 (fi) | 1994-04-15 |
WO1993008299A1 (en) | 1993-04-29 |
PT100980A (pt) | 1994-01-31 |
PT100980B (pt) | 1999-07-30 |
NO941376L (no) | 1994-06-17 |
JPH06511154A (ja) | 1994-12-15 |
NO310417B1 (no) | 2001-07-02 |
CA2121121A1 (en) | 1993-04-29 |
CA2121121C (en) | 2003-06-10 |
EP0620860A4 (en) | 1997-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI942017A0 (fi) | Ihmisen interferonin stabilointi | |
ATE190066T1 (de) | Neuartige peptidderivate | |
ATA257190A (de) | Virales polypeptid | |
DK19991D0 (da) | Proteinpraeparationer | |
DK603888D0 (da) | Rekombinant virus | |
DE69220382D1 (de) | Verwendung von Peptidderivaten | |
DK38293D0 (da) | Fremstilling af proteiner | |
HUT58371A (en) | Recombinant virus of marek-disease | |
KR950702242A (ko) | 사포린 함유 단백질의 재조합 생산방법(Recombinant production of saporin-containing proteins) | |
DK132892D0 (da) | Proteiner | |
FI941749A (fi) | Rekombinantti-Borrelia -proteiinien valmistus | |
DK549688D0 (da) | Fremstilling af peptider | |
DK273089A (da) | Anvendelse af peptidderivater | |
DK395288D0 (da) | Proteiner | |
DE69120700D1 (de) | Polypeptidepaar | |
FI934588A0 (fi) | Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben | |
FI944997A0 (fi) | Parannettu rekombinantti-proteiinien tuotanto | |
NO934602D0 (no) | Fremgangsmaate for fremstilling av polypeptider | |
DK82592D0 (da) | Fremstilling af proteiner | |
DK354989D0 (da) | Modificerede proteiner | |
NO891926D0 (no) | Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater. | |
GB9104596D0 (en) | Production of recombinant proteins | |
DK149591A (da) | Proteinpraeparat | |
NO941982D0 (no) | Fremstilling av proteiner ved anvendelse av 7B2 protein | |
DK147891D0 (da) | Proteinpraeparat |